CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE
Active substance: CHLORDIAZEPOXIDE HYDROCHLORIDE, CLIDINIUM BROMIDE
CAPSULE · CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1, CLIDINIUM BROMIDE 2.5 mg/1
United StatesActive
Marketing holder: Micro Labs Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- CHLORDIAZEPOXIDE HYDROCHLORIDE · 5 mg/1
- CLIDINIUM BROMIDE · 2.5 mg/1
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 3 |
|
Control by country
- RussiacontrolledSchedule: ПIII
Source: GRLS (Russian state register) · record 01a120c4-32c7-77fa-b7bc-cb35404f7919;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208c-5b9c-7dbc-82b3-9b010c888084,01a1208c-5be3-788e-8b4c-fe88a75ccd76,01a1208c-8815-7a13-aedb-b029af316bf9,01a1208c-cff0-774c-ab20-23d054cf7251,01a1208d-258e-77b4-a531-f31b5f4c62c7;count=28 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 42571-381
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
- product · openFDA NDC · 42571-381 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42571-381 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42571-381 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 42571-381 · Verified 2026-10-09 · open in source